Assignee
3B PHARMACEUTICALS GMBH
DE·3 granted patents·9 pending applications·6 citations·filing 2013–2025
Top patents by PatentIndex Score
12 records- 0180US10961199B2Neurotensin receptor ligands3B PHARMACEUTICALS GMBH·Filed 2013·Granted Mar 30, 2021·3 cites·26 claims
- 0279US10799605B2Conjugate comprising a neurotensin receptor ligand and use thereof3B PHARMACEUTICALS GMBH·Filed 2015·Granted Oct 13, 2020·3 cites·36 claims
- 0370US2026078095A1Neurotensin receptor ligands3B PHARMACEUTICALS GMBH·Filed 2025·Application pending·0 cites
- 0469US2026061086A1Compounds comprising a fibroblast activation protein ligand and use thereof3B PHARMACEUTICALS GMBH·Filed 2025·Application pending·0 cites
- 0560US2021087149A1Neurotensin receptor ligands3B PHARMACEUTICALS GMBH·Filed 2020·Application pending·0 cites
- 0656US12427210B2Compounds comprising a fibroblast activation protein ligand and use thereof3B PHARMACEUTICALS GMBH·Filed 2020·Granted Sep 30, 2025·0 cites·55 claims
- 0755US2026083865A1Prostate specific membrane antigen (psma) ligands and use thereof3B PHARMACEUTICALS GMBH·Filed 2023·Application pending·0 cites
- 0854US2025296971A1Gastric inhibitory peptide receptor ligands3B PHARMACEUTICALS GMBH·Filed 2022·Application pending·0 cites
- 0954US2024115745A1Compounds comprising a fibroblast activation protein ligand and use thereof3B PHARMACEUTICALS GMBH·Filed 2022·Application pending·0 cites
- 1054US2025339569A1Carbonic anhydrase ix ligands3B PHARMACEUTICALS GMBH·Filed 2022·Application pending·0 cites
- 1150US2023212549A1Compounds comprising a fibroblast activation protein ligand and use thereof3B PHARMACEUTICALS GMBH·Filed 2022·Application pending·0 cites
- 1244US2022315554A1Compounds comprising a fibroblast activation protein ligand and use thereof3B PHARMACEUTICALS GMBH·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when 3B PHARMACEUTICALS GMBH files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →